2019
DOI: 10.1016/j.suc.2019.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Extent of Surgery for Low-Risk Differentiated Thyroid Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 47 publications
0
30
0
1
Order By: Relevance
“…Unlike those with many other malignancies, patients with localized PTC have excellent long-term survival-99.9% at 10 years (2). Patients at low risk for recurrence also have an excellent prognosis regardless of the extent of thyroidectomy (3,4). The American Thyroid Association (ATA) updated guidelines for managing these patients in 2015 (1,5).…”
Section: Introductionmentioning
confidence: 99%
“…Unlike those with many other malignancies, patients with localized PTC have excellent long-term survival-99.9% at 10 years (2). Patients at low risk for recurrence also have an excellent prognosis regardless of the extent of thyroidectomy (3,4). The American Thyroid Association (ATA) updated guidelines for managing these patients in 2015 (1,5).…”
Section: Introductionmentioning
confidence: 99%
“…This phenomenon cannot be fully explained by improvements in the sensitivity of testing methods, nor increased awareness among doctors and patients of screening. 9 Scholars from other countries have actively researched the risk factors associated with thyroid cancer, and found that autoimmune disorders, ionizing radiation, iodine intake, estrogen, environmental endocrine disruptors, negative psychosocial factors, and heredity may contribute to increases in thyroid cancer incidence. 10,11 From 1984 to 2010, the incidence of differentiated thyroid carcinoma in the United States increased, with tumors of diameter ≤ 0.5 rising by 5.09%, while those of 0.5-0.99 cm in diameter increased by 8.45%, average diameter tumors (1.0-1.99 cm) by 3.42%, and large tumors ≥ 2.0 cm by 2.96%.…”
Section: Discussionmentioning
confidence: 99%
“…Any cancer that initially occurs is not late-stage advanced papillary thyroid carcinoma (PTC). 7,8 The incidence of lymph node metastasis in patients with central region PTC is 20-66%, 9,10 which indicates that although PTC progresses slowly, its ability and tendency to metastasize to lymph nodes are obvious, and even for distant organs. It is unscientific to classify malignant tumors based on tumor size, as the invasiveness and distant metastatic ability of tumors are a consequence of the evolution of the tumor genome.…”
Section: Introductionmentioning
confidence: 99%